ROPIVACAINE KABI ropivacaine hydrochloride 50 mg/10 mL solution for injection ampoule (195805)

ARTG ID 195805

ARTG Name

ROPIVACAINE KABI ropivacaine hydrochloride 50 mg/10 mL solution for injection ampoule

Product name

ROPIVACAINE KABI ropivacaine hydrochloride 50 mg/10 mL solution for injection ampoule

ARTG Date

13 June 2013

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

ropivacaine hydrochloride

Licence category

RE

Licence status

A

Summary

Product information

Consumer medicine information

Related information

ROPIVACAINE KABI ropivacaine hydrochloride 50 mg/10 mL solution for injection ampoule (2023-24)

2023-24

Annual charge exemption

Exempt from annual charge in 2023-24 due to Fresenius Kabi Australia Pty Ltd declaring $0 turnover in that period.
ROPIVACAINE KABI ropivacaine hydrochloride 50 mg/10 mL solution for injection ampoule, Fresenius Kabi Australia Pty Ltd, CON-747

3 February 2021

Section 14 consent

Consent to while noncompliant with standards.
ROPIVACAINE KABI ropivacaine hydrochloride 50 mg/10 mL solution for injection ampoule, Fresenius Kabi Australia Pty Ltd, CON-747

3 February 2021

Section 14 consent

Consent to while noncompliant with standards.